A prospective, multicenter, randomized controlled trial for clinical treatment of cesarean scar pregnancy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024793

Enrollment

Unknown

Registered

2019-07-27

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean scar pregnancy

Interventions

Case series:surgical treatment

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-45 years old; 2. The gestational age 6-12 weeks, 3. Clinical diagnosis of uterine scar pregnancy by ultrasound; 3. Normal liver and kidney function; 5. Sign informed consent and be willing to comply with this test plan.

Exclusion criteria

Exclusion criteria: 1. The patients had shock signs (systolic blood pressure 100 beats/minute, or urine volume < 30 mL/h); 2. Treated by relative medicines and surgery; 3. Participating in other interventional clinical trials.

Design outcomes

Primary

Measure	Time frame
Scar thickness;Gestational sac diameter;Intraoperative bleeding volume;Hospitalization days after operation;	—

Secondary

Measure	Time frame
pregnancy outcome;Menstrual recovery;	—

Countries

China

Contacts

Public ContactShixuan Wang

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

sxwang@tjh.tjmu.edu.cn+86 027 83663816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026